mentioned method using 0.45 mmol of L-
histidine and 0.90 mmol of TsOH. β-
Alanine•TsOH was redissolved in thionyl
chloride (0.6 mL) and incubated for 1 h at room
temperature, dried in vacuo and then dissolved
in toluene (0.4 mL). β-alanineCl•TsOH was
dried in vacuo again. All the synthesized β-
alanineCl•TsOH and L-histidine•2TsOH were
mixed in N,N-dimethylacetamide (0.45 mL),
purged with nitrogen, and incubated for 1 h at
containing 50% acetonitrile and 100 mM
ammonium formate) (0% B at 0 min; 90% B at
20 min) at the flow rate of 1.5 mL/min. The
elution was monitored by absorbance at 250 nm.
The chemical structures of the products were
characterized by LC-ESI-MS/MS and NMR
analysis. The NMR analyses were performed
using a JEOL JNM-ECZ500R (500 MHz)
1
instrument. 2-Oxo-carnosine: H NMR (D
2
O):
δH 2.54 (dt, J = 3.5 Hz, 2H), 2.66 (dd, J = 8.2
Hz, 1H), 2.80 (dd, J = 5.5 Hz, 1H), 3.06 (t, J =
6.8 Hz, 2H), 4.41 (dd, J = 4.7 Hz, 1H), 6.12 (s,
1H); δC 31.34, 35.83, 39.70, 56.61, 119.01,
4
°C with shaking. An equal amount of water
was added to the mixture to hydrolyze the
unreacted β-alanineCl•TsOH. The obtained
1
3
15
[
(
C
3
,
N] carnosine was purified by HPLC
132.18, 159.10, 176.06, 179.17. 2-Oxo-
1
JASCO Corporation, Tokyo, Japan) under the
anserine: H NMR (D
2
O): δH 2.26 (dt, J = 3.1
following conditions: a Scherzo SS-C18
column (6.0 x 100 mm, Imtakt, Kyoto, Japan)
using a linear gradient of solvent A (water
containing 0.1% formic acid) and solvent B
Hz, 2H), 2.60 (dd, J = 10 Hz, 1H), 2.70 (t, J =
6.5 Hz, 2H), 2.84 (m, 1H), 3.05 (s, 3H), 4.26 (dd,
J = 4.7 Hz, 1H), 6.12 (s, 1H); δC 29.10, 31.92,
37.67, 38.87, 55.07, 117.95, 129.67, 155.86,
1
(
water containing 50% acetonitrile and 100 mM
ammonium formate) (0% B at 0 min; 75% B at
0 min) at the flow rate of 1.0 mL/min. The
elution was monitored by absorbance at 220 nm.
-Methyl-L-histidine was used for the
175.47, 179.10. 2-Oxo-homocarnosine:
NMR (D
H
2
O): δH 1.72-1.75 (m, 2H), 2.21 (dt, J
2
= 3.5 Hz, 2H), 2.53 (dd, J = 8.2 Hz, 1H), 2.76-
2.81 (m, 3H), 4.23 (dd, J = 4.7 Hz, 1H), 6.08 (S,
1H); δC 24.41, 29.46, 33.86, 40.21, 55.46,
116.34, 129.51, 164.25, 175.61, 178.91.
3
13
15
preparation of [ C
histidine. γ-Aminobutyric acid and [ N
3
, N] anserine, instead of L-
15
3
] L-
1
5
histidine were used for the preparation of [ N
3
]
LC-ESI-MS/MS analysis
homocarnosine, instead of β-alanine and L-
histidine, respectively. The chemical structures
of the products were characterized by LC-ESI-
MS/MS and NMR analyses.
The LC-ESI-MS/MS analyses were
carried out using the Xevo TQD triple
quadrupole mass spectrometer (Waters, MA,
USA). Chromatography was carried out by an
Intrada Amino Acid column (2.0 x 50 mm,
Imtakt) using an Alliance e2695 system (Waters,
MA, USA). A discontinuous gradient of solvent
A (acetonitrile containing 0.1% formic acid)
and solvent B (water containing 100 mM
ammonium formate) was used as follows: 0% B
at 0 min, 60% B at 0.1 min, 70% B at 5 min,
99% B at 9 min, at the flow rate of 0.3 mL/min.
The mass spectrometer operated in the positive
mode under the following conditions: capillary
voltage 1000 V and desolvation gas (nitrogen)
1000 L/h at 500 °C. The oxidized imidazole
dipeptides were identified and quantified in the
Preparation of oxidized IDPs
Oxidation of the imidazole ring of the
IDPs was carried out by the ascorbic acid-
copper ion system (12). The reaction mixtures
(
5 mL) containing 10 mM IDPs, 200 mM
sodium phosphate buffer (pH 7.2), 200 mM
ascorbate, and 2 mM CuSO were incubated at
4
room temperature. Oxygen gas was bubbled
into the mixture for 30 min. The oxidized IDPs
were purified under the following conditions: a
Scherzo SS-C18 column (6.0 x 100 mm) using
a linear gradient of solvent A (water containing
0.1% formic acid) and solvent B (water
9